Persisting or Worsening Impulse Control Disorders in Parkinson's Disease Following a Switch to Subcutaneous Foslevodopa‐Foscarbidopa
Movement Disorders Clinical Practice2026
Maeve Bradley, Eoghan Donlon, Amy Gallagher, Federica Ruggieri, John Inocentes, Antonio Diaz Rua, Clodagh O’Keeffe, T. H. Lynch, Conor Fearon, Richard A. Walsh
Abstract
CSFLI may exacerbate ICDs in susceptible individuals. Pre-treatment screening and close monitoring are recommended.